The impact of treatment duration on relapse rates and health care costs among medicaid patients with opioid dependence treated with buprenorphine/naloxone
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.1261
https://www.valueinhealthjournal.com/article/S1098-3015(14)01312-6/fulltext
Section Title :
Mental Health
Section Order :
721
First Page :
A215
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01312-6&doi=10.1016/j.jval.2014.03.1261